Innate Pharma to participate in upcoming investor conferences

Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”) announced today that members of its senior management team are scheduled to participate in the following upcoming virtual investor conferences.

  • ODDO BHF Digital Forum

Date: January 7-11, 2021

  • SternIR Virtual Corporate Access Event

Date: January 11-14, 2021
Presentation: A pre-recorded presentation will be available for on-demand viewing in the Investors section of the Innate Pharma website,, beginning Monday, January 11, 2021.